Prevalence of gastrointestinal symptoms in coronavirus disease 2019: a meta-analysis

E Merola1, F Armelao1, G de Pretis1

  • 1Department of Gastroenterology, Azienda Provinciale per i Servizi Sanitari di Trento (APSS), Trento, Italy.

Insights

Gastrointestinal symptoms, including diarrhea, affect over 11% of COVID-19 patients. Viral RNA is present in stool samples, and asymptomatic cases may contribute to transmission.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 (coronavirus disease 2019) is a global pandemic.
  • Gastrointestinal (GI) involvement in COVID-19 requires further investigation.

Purpose of the Study:

  • To assess the frequency of GI manifestations in COVID-19 patients.
  • To determine the prevalence of COVID-19 in stool samples.
  • To evaluate the proportion of asymptomatic COVID-19 cases.

Main Methods:

  • Systematic review and meta-analysis of studies published until March 25, 2020.
  • Included 33 studies with 4434 COVID-19 patients.
  • Utilized a random-effects model for pooled prevalence estimation.

Main Results:

  • 11.51% of COVID-19 patients exhibited GI symptoms, with diarrhea being the most common (7.78%).
  • COVID-19 positivity in stool samples was found in 41.50% of cases.
  • 11.85% of COVID-19 patients were asymptomatic.

Conclusions:

  • A significant number of COVID-19 patients present with GI symptoms.
  • COVID-19 RNA is detectable in stool, indicating potential fecal-oral transmission.
  • Asymptomatic individuals may play a role in viral spread.
Abstract

Related Concept Videos

Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
476
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
303
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
543
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
355
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
452
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
825